Posted on July 1st, 2015
Craig A. Dionne, PhD, is one of GenSpera's founders and has served on our board since November 2003.
Company OverviewGenSpera unlocks conventional thinking to conceive, design, and develop curative cancer therapies that are core to the principles of finding the best way to cure or extend human life. Its innovative approach to drug delivery is expected to maximize anti-tumor activity and minimize side effects. GenSpera’s technology platform combines a powerful, plant-derived cytotoxin (thapsigargin) with a prodrug delivery system that provides for the targeted release of drug candidates within a tumor. GenSpera's lead drug candidate, mipsagargin, is activated by the enzyme PSMA, which is found at high levels in the blood vessels of liver and glioblastoma cancers and in the blood vessels of almost all other solid tumors. Mipsagargin is therefore expected to have potential efficacy in a wide variety of tumor types. The US Food and Drug Administration (FDA) granted Orphan Drug designation in 2013 for the evaluation of mipsa... Learn More »
The increasing costs of healthcare in the United States is a central point of discussion for economists and legislators ...Read More »
Posted on June 15th, 2015
The World Orphan Drug Conference (WODC) took place on April 23rd-24th, 2015. This conference is an annual gauge of the r...Read More »
Posted on June 8th, 2015
I recently attended the Annual American Society for Clinical Oncology (ASCO) meetings in Chicago. It is a very busy conf...Read More »
Posted on June 1st, 2015
Interest in orphan diseases has increased at a feverish pace over the course of the last decade. But it was not always t...Read More »
Posted on May 27th, 2015
Last Thursday we held our “SF Explorers Meeting,” where we invite technical staff and advisers to meet with our boar...Read More »
Reveal Insights About Your Company and Industry to Shareholders.
The Chairman's Blog is an exclusive, online media publication where publicly and privately held firms alike share insights about their companies and industries. The Chairman's Blog enables upper tier management to discuss issues that are of importance to their stakeholders, shareholders, and interested parties in an informal environment. Learn More »